FDBusiness.com

Nestlé Investing in Breakthrough ‘Ecobiotics’ to Tackle Serious Public Health Issues

 Breaking News
  • Administrators Appointed to Russell Hume KPMG Restructuring has been appointed as administrators to Russell Hume, the UK specialist meat supplier. Headquartered in Derby and operating from six production sites in Liverpool, Birmingham, London, Boroughbridge, Exeter and Fife, the company supplied meat to a number of hotels, restaurants and pubs across the UK. It employed a total of 302 people. Last month, [...]...
  • Heineken Delivers a Solid 2017 Performance Heineken has posted a 5% increase in organic revenue (beia) to €21.91 billion for 2017 with revenue (beia) per hectolitre up by2.1% as consolidated beer volume rose by 3.0% with growth in all regions. Operating profit (beia) grew 9.3% organically during the year, primarily reflecting higher revenue and cost efficiencies. The group’s operating margin improved [...]...
  • Coca-Cola European Partners Reports First Full Year Coca-Cola European Partners has reported a 21% increase in revenue to €11.1 billion – up 3.0% on a comparable and foreign exchange neutral basis – for the full-year ended 31 December 2017. Volume was up 0.5% on a comparable basis. Full-year reported operating profit at €1.3 billion was up 9.0% and by 10.5% on a comparable [...]...
  • New Micronutrient Premix For Target-group-specific Drinks Health is one of the twelve central megatrends identified by the Frankfurt Future Institute’s Food Report 2018. A healthy lifestyle is important to all age groups, and nutrition plays a major role alongside various other components. Using its new premix for healthy bones and heart as an example, SternVitamin shows how beverage manufacturers can address [...]...
  • Lete SpA – A Compact Line of 44,000 bph For Square Bottles Lete is an internationally recognised trademark, thanks to the peculiarity of the naturally sparkling water and also because it is the main sponsor of Napoli Calcio. The collaboration with ACMI dates back more than twenty years and the famous Italian supplier of end-of-lines has always considered Lete SpA to be one of its most prestigious [...]...

Nestlé Investing in Breakthrough ‘Ecobiotics’ to Tackle Serious Public Health Issues

Nestlé Investing in Breakthrough ‘Ecobiotics’ to Tackle Serious Public Health Issues
January 13
09:32 2016

Nestlé Health Science has signed an exclusive agreement outside of the United States and Canada to support the potential future commercialisation of Seres Therapeutics’ novel ‘microbiome therapeutics’. The aim is to treat Inflammatory Bowel Disease (IBD) and Clostridium difficile (C.diff), an intestinal infection caused by the C.diff bacteria that can be life-threatening in some cases.

Nestlé Health Science will invest SFr121 million (US$120 million) upfront to support Seres’ ‘Ecobiotics’, a new class of biological drugs based upon microbial organisms. These target the microbiome – the 100 trillion microorganisms that live in the body.

Scientific research increasingly links an unhealthy or unbalanced microbiome to a range of health conditions, including IBD and C.diff.

Greg Behar, chief executive of Nestlé Health Science and Seres Therapeutics Board member, says: “With this strategic move we demonstrate our intent to be a leader in bringing breakthrough healthcare approaches to market that transform patient outcomes and create value in healthcare system around the world. We are partnering with Seres, a clear leader in advancing their pipeline in the fast evolving microbiome field. We bring our worldwide footprint and capabilities in managing acute care and gastrointestinal (GI) related conditions through our diagnostics, nutritional solutions and innovative pipeline. Moreover, we bring our strong relationships with key opinion leaders, healthcare professionals and patient organizations as well as our experience in clinical development, regulatory and market access in IBD. Together with Seres Therapeutics, we will focus on successfully bringing this pipeline to patients and create innovative therapeutic approaches.”

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • February 18, 2018Vinisud
  • February 25, 2018fish international
  • February 27, 2018Int'l Food Fair
  • February 27, 2018Warsaw Gastro Show
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements